High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in Neuroblastoma

BACKGROUND: Current clinical risk factors stratify patients with neuroblastoma (NB) for appropriate treatments, yet patients with similar clinical behaviors evoke variable responses. MYCN amplification is one of the established drivers of NB and, when combined with high-risk displays, worsens outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Divya, Ho, Shinn-Ying, Juan, Hsueh-Fen, Huang, Hsuan-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649748/
https://www.ncbi.nlm.nih.gov/pubmed/31360848
http://dx.doi.org/10.1093/jncics/pky015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649748/
https://www.ncbi.nlm.nih.gov/pubmed/31360848
http://dx.doi.org/10.1093/jncics/pky015

Ejemplares similares